发明名称 3-(HETEROARYLOXY)-2-ALKYL-1-AZABICYCLOALKYL DERIVATIVES AS LIGANDS OF ALPHA-7-nAChR (NICOTINIC ACETYLCHOLINE RECEPTORS), MEANT FOR TREATING CENTRAL NERVOUS SYSTEM DISEASES
摘要 FIELD: chemistry. ^ SUBSTANCE: invention relates to novel compounds of formula I , in which A denotes hydrogen, B denotes methyl or B is in a trans-position relative oxygen; X denotes CH2; Y denotes a group of formula , , , ^ , or ; ^ , in which the left-hand bond is to an oxygen atom, and the right-hand bond is to the group R; R denotes 5-indolyl; in form of a free base or an acid addition salt. The invention also relates to a pharmaceutical composition, to use of compounds in any of claims 1-7, to a method of preventing and treating psychiatric and neurodegenerative disorders in a person, as well as a method of treating and preventing diseases or pathological condition in which 7 nAChR activation plays a role. ^ EFFECT: obtaining novel biologically active compounds having 7 nAChR agonist activity. ^ 16 cl, 4 ex
申请公布号 RU2402551(C2) 申请公布日期 2010.10.27
申请号 RU20070105350 申请日期 2005.07.13
申请人 NOVARTIS AG 发明人 FOJERBAKH DOMINIK;ROJ BERNAR LJUS'EN;KHURT KONSTANTSE;FREDERIKSEN MATTIAS
分类号 A61K31/439;A61P25/00;C07D453/02;C07D487/08 主分类号 A61K31/439
代理机构 代理人
主权项
地址